NCT01771172

Brief Summary

To assess the defibrillation efficacy of a subcutaneous defibrillation system.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2013

Geographic Reach
5 countries

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 18, 2013

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2013

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

December 2, 2016

Completed
Last Updated

December 2, 2016

Status Verified

October 1, 2016

Enrollment Period

1 year

First QC Date

January 16, 2013

Results QC Date

October 10, 2016

Last Update Submit

October 10, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Subjects Will Demonstrate a Successful Defibrillation Outcome if They Have 2 Successful Defibrillation Shocks With the Research System.

    within the first day

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects may be either male or female, and must meet all of the inclusion criteria and none of the exclusion criteria of the study

You may qualify if:

  • Subject must be undergoing implant of a commercially approved ICD system
  • Subject must be willing to provide Informed Consent
  • Subject must be \> 18 years old

You may not qualify if:

  • Subject with impaired kidney function as measured by a glomerular filtration rate (eGFR) estimate \< 29 mls/min/1.73m2 (recorded in the last six months)
  • Subject has high risk of infection
  • Subject has EF \< 15%
  • Subject at high risk of stroke
  • having a device replacement
  • Subject with an implanted active non-ICD device, cardiac or non-cardiac (e.g., Neuro stimulator, Pacemaker)
  • Subject is indicated for CRT
  • Subject is pacemaker dependent
  • Subject enrolled in a concurrent study that may confound the results of this study
  • Subject has medical conditions that would limit study participation
  • Subject is pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Republican Scientific and Practical Center Cardiology

Minsk, Belarus

Location

Rigshospitalet

Copenhagen, Denmark

Location

St. Antonius Ziekenhuis

Nieuwegein, Netherlands

Location

Erasmus MC

Rotterdam, Netherlands

Location

Slovak Medical University

Bratislava, Slovakia, 83348, Slovakia

Location

Dudley Group NHS-Russells Hall Hospital

Dudley, United Kingdom

Location

King's College Hospital

London, United Kingdom

Location

Southhampton General Hospital

Southhampton, United Kingdom

Location

Results Point of Contact

Title
Medtronic CRDM Clinical Trial Manager
Organization
Medtronic, Inc.

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2013

First Posted

January 18, 2013

Study Start

May 1, 2013

Primary Completion

May 1, 2014

Study Completion

June 1, 2014

Last Updated

December 2, 2016

Results First Posted

December 2, 2016

Record last verified: 2016-10

Locations